ESOFIGHT-DSR Capsules is a clinically advanced combination therapy formulated for the effective treatment of acid reflux, GERD (Gastroesophageal Reflux Disease), hyperacidity, heartburn, bloating, and gastritis.

Esomeprazole, a proton pump inhibitor (PPI), works by reducing gastric acid secretion through inhibition of the H+/K+ ATPase enzyme system in the stomach lining. Domperidone (Dual Sustained Release) enhances gastric motility and accelerates gastric emptying, thereby preventing acid reflux and nausea.

This dual mechanism provides:

• Long-lasting acid suppression

• Reduced regurgitation and acidity

• Relief from nausea and fullness

• Improved digestive comfort

ESOFIGHT-DSR is widely prescribed in cases of:

• GERD and reflux esophagitis

• Chronic hyperacidity

• Peptic ulcer disease

• Drug-induced gastritis

• Functional dyspepsia

The sustained-release technology ensures better bioavailability and prolonged therapeutic effect with improved patient compliance.

Marketed by Varmed Pharma Pvt Ltd, ESOFIGHT-DSR is a high-demand brand in the gastro range under the PCD Pharma Franchise segment, offering excellent market growth opportunities.

SEO Keywords: Esomeprazole DSR capsules, GERD treatment India, acidity medicine PCD franchise, best PPI combination brand, Varmed Pharma Pvt Ltd.